Litcius/Paper detail

Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 Years

Michael Haude, Ralph Töelg, Pedro A. Lemos, Evald Høj Christiansen, Alexandre Abizaid, Clemens von Birgelen, Franz–Josef Neumann, William Wijns, Hüseyin İnce, Christoph Kaiser, Soo Teik Lim, Javier Escaned, Éric Eeckhout, Héctor M. García‐García, Ron Waksman

2021Cardiovascular revascularization medicine28 citationsDOI

Topics & Concepts

MedicineSirolimusTerm (time)ScaffoldInternal medicineSurgeryBiomedical engineeringPhysicsQuantum mechanicsCoronary Interventions and DiagnosticsPeripheral Artery Disease ManagementAortic aneurysm repair treatments
Sustained Safety and Performance of a Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Long-Term Data of the BIOSOLVE-II First-in-Man Trial at 5 Years | Litcius